Evidence mapPaperPMID 33257421Full record

ArticleBMJ open diabetes research & care2020

Long-term variability of glycemic markers and risk of all-cause mortality in type 2 diabetes: the Look AHEAD study.

Arnaud D Kaze, Prasanna Santhanam, Sebhat Erqou, Rexford S Ahima, Justin Basile Echouffo-Tcheugui

Abstract read
In one paragraph

Article in BMJ open diabetes research & care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 6 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Glucose Variability: How Does It Work?International journal of molecular sciences · 2021
    Review
  17. Article
  18. Glycemic variability and cardiovascular disease in patients with type 2 diabetes.BMJ open diabetes research & care · 2021 · on this map
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arnaud D KazeDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-5470-8296
Prasanna SanthanamDepartment of Medicine, Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sebhat ErqouAlpert Medical School of Brown University, Providence, Rhode Island, USA.
Rexford S AhimaDepartment of Medicine, Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Justin Basile Echouffo-TcheuguiDepartment of Medicine, Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA jechouf1@jhmi.edu.ORCID 0000-0002-8460-1617

Funding

CORE--GENETICS, GENOMICS, AND GENETIC EPIDEMIOLOGYP30DK072488 · UNIVERSITY OF MARYLAND BALTIMORE · 2005 to 2005
$1.0M
NIDDK NIH HHS P30 DK072488
6 · The paper itself

Abstract

introductionGlycemic variability may predict poor outcomes in type 2 diabetes. We evaluated the associations of long-term variability in glycosylated hemoglobin (HbA RESEARCH DESIGN AND

methodsWe conducted a secondary, prospective cohort analysis of the Look AHEAD (Action for Health in Diabetes) data, including 3560 participants who attended four visits (baseline, 12 months, 24 months, and 36 months) at the outset. Variability of HbA

resultsOver a median follow-up of 6.8 years, there were 164 deaths from any cause, 33 CVD-related deaths, 91 HF events, and 340 participants experienced the CVD composite. Adjusted HRs comparing the highest to lowest quartile of SD of HbA

conclusionsA greater variability in HbA

Indexed as

Blood GlucoseDiabetes Mellitus, Type 2Follow-Up StudiesHumansProspective StudiesRisk FactorsBlood Glucosecardiovascular systemdiabetes mellitusmortalitytype 2

Identifiers

PMID33257421
PMCPMC7705503

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.